Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Illumina Inc (NQ: ILMN )

117.07 +0.38 (+0.33%)
Streaming Delayed Price Updated: 1:26 PM EDT, Apr 19, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Illumina Inc

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
26 27 Next >
Peering Into Illumina's Recent Short Interest
Via Benzinga
IEP Stock Alert: Regulators Request Information From Icahn Enterprises
Icahn Enterprises suffered sharply related to the earlier short-seller attack, sending IEP stock down as it feels the heat of “activism.” 
Via InvestorPlace
Illumina Unusual Options Activity
Via Benzinga
Hestia Insight Inc. Signs Letter of Intent With Major Asian-Pacific Health Care Products Distributor
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Intellectual Property
Exposures Intellectual Property
Illumina Unusual Options Activity
Via Benzinga
Better Gene Sequencing Stock: Illumina vs. Bionano Genomics
This is a classic matchup of a grizzled top dog against a scrappy competitor. 
Via The Motley Fool
Why Illumina Fell 11.6% in April
The gene-sequencing company reported weaker results while the Federal Trade Commission has ordered it to divest its Grail acquisition. 
Via The Motley Fool
Here's How Much You Would Have Made Owning Illumina Stock In The Last 10 Years
Via Benzinga
Illumina Unusual Options Activity
Via Benzinga
A Look Into Illumina's Debt
Via Benzinga
Will Forced Divesture Of Grail Boost Illumina Shareholder Value?
Regulators may force Illumina to divest Grail, which it acquired in 2021. Carl Icahn is also calling for a divestiture. The move could benefit shareholders. 
Via MarketBeat
7 Stocks Poised for a Major Breakout in May 2023
These best breakout stocks are set for an impressive rebound ahead as the stock market starts picking up the pace again 
Via InvestorPlace
Market Rally Wobbles Amid Big Earnings Moves From Microsoft, Meta, Crocs, Cloudflare: Weekly Review
Microsoft, Meta, Cloudflare and Crocs were among the many big movers. 
Via Investor's Business Daily
FDA Warns Cybersecurity Vulnerability For Illumina Sequencers
The FDA issued a letter noting that nearly the 
Via Benzinga
Here's How Much You Would Have Made Owning Illumina Stock In The Last 10 Years
Via Benzinga
Baird Maintains Neutral Rating for Illumina: Here's What You Need To Know
Via Benzinga
Microsoft Strikes Nware Deal to Woo European Officials Over Activision Acquisition, Lyft Lay-offs Over 1K Employees, Big Oil Earnings: Top Stories For Today
Benzinga 
Via Benzinga
3 Telemedicine Stocks to Watch as Healthcare Goes Digital
The telemedicine stocks discussed in the article offer incredible upside ahead in the fast-evolving telehealth sector 
Via InvestorPlace
Realtimecampaign.com Discusses Some of the Many Benefits of Genotyping
Via Get News
Illumina's Q1 Revenue Drop, Dwindling Margins: Outlines Cost Cutting Plans With $100M Savings
Via Benzinga
Illumina Narrowly Squeaks Out First-Quarter Beat As Grail Battle Continues
The company is fighting both regulators and its own shareholders to retain Grail. 
Via Investor's Business Daily
This Is What Whales Are Betting On Illumina
Via Benzinga
A Preview Of Illumina's Earnings
Via Benzinga
Looking At Illumina's Recent Unusual Options Activity
Via Benzinga
Profit from the Artificial Intelligence Boom with These 7 AI ETFs
The artificial intelligence revolution is already here, creating a massive $1.81 trillion opportunity for AI ETFs. 
Via InvestorPlace
Cleveland-Cliffs: A Steel Producer To Target In This Resilient Market
One of the nice things about “boring” markets is that they do not require a lot of “rethinking of things,” and given just how resilient this market has been in the face of all that has been thrown at... 
Via Talk Markets
Here's Why You Shouldn't Buy the Dip With Illumina Stock
There aren't many factors driving its growth at the moment. 
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
What Does Illumina's Debt Look Like?
Via Benzinga
Hillstream BioPharma's Drug Candidate HSB-1216 Could Be One To Watch As Global Oncology Market Continues To Grow
A surge in oncology drug development, coupled with increased patient access and early diagnosis, has resulted in a massive increase in global spending on cancer treatments. Due to this, the global... 
Via Benzinga
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
26 27 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.